Drug Information

Drug General Information
Drug ID
D01ZNQ
Former ID
DIB002640
Drug Name
TMC-310911
Indication Human immunodeficiency virus infection [ICD9: 279.3; ICD10:B20-B26] Phase 2 [522572]
Company
Janssen research & development
Structure
Download
2D MOL
Target and Pathway
Target(s) HIV protease Target Info Inhibitor [551655]
References
Ref 522572ClinicalTrials.gov (NCT00838162) A Study to Determine the Antiviral Activity of TMC310911 When Administered With Ritonavir in Treatment-Naive Human Immunodeficiency Virus - Type 1 (HIV-1) Infected Patients. U.S. National Institutes of Health.
Ref 551655Oral Druggable Space beyond the Rule of 5: Insights from Drugs and Clinical Candidates. Chemistry & Biology Volume 21, Issue 9, 18 September 2014, Pages 1115-1142.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.